vs

Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Via Renewables, Inc. (VIASP). Click either name above to swap in a different company.

Via Renewables, Inc. is the larger business by last-quarter revenue ($127.8M vs $123.8M, roughly 1.0× NATURES SUNSHINE PRODUCTS INC). Via Renewables, Inc. runs the higher net margin — 5.4% vs 3.3%, a 2.0% gap on every dollar of revenue. On growth, Via Renewables, Inc. posted the faster year-over-year revenue change (22.5% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-4.8M). Over the past eight quarters, Via Renewables, Inc.'s revenue compounded faster (5.9% CAGR vs 5.6%).

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

EDF Power Solutions is a wholly owned subsidiary of the French utility EDF Group, specializing in renewable energy production. As an integrated operator, the Group develops and finances the construction of renewable energy facilities, and manages operations and maintenance for its own account and for third parties.

NATR vs VIASP — Head-to-Head

Bigger by revenue
VIASP
VIASP
1.0× larger
VIASP
$127.8M
$123.8M
NATR
Growing faster (revenue YoY)
VIASP
VIASP
+17.8% gap
VIASP
22.5%
4.7%
NATR
Higher net margin
VIASP
VIASP
2.0% more per $
VIASP
5.4%
3.3%
NATR
More free cash flow
NATR
NATR
$12.3M more FCF
NATR
$7.6M
$-4.8M
VIASP
Faster 2-yr revenue CAGR
VIASP
VIASP
Annualised
VIASP
5.9%
5.6%
NATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NATR
NATR
VIASP
VIASP
Revenue
$123.8M
$127.8M
Net Profit
$4.1M
$6.9M
Gross Margin
72.5%
34.4%
Operating Margin
4.3%
15.2%
Net Margin
3.3%
5.4%
Revenue YoY
4.7%
22.5%
Net Profit YoY
1379.4%
-30.9%
EPS (diluted)
$0.23
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NATR
NATR
VIASP
VIASP
Q4 25
$123.8M
$127.8M
Q3 25
$128.3M
$103.3M
Q2 25
$114.8M
$90.0M
Q1 25
$113.2M
$142.3M
Q4 24
$118.2M
$104.3M
Q3 24
$114.6M
$93.8M
Q2 24
$110.6M
$86.7M
Q1 24
$111.0M
$114.1M
Net Profit
NATR
NATR
VIASP
VIASP
Q4 25
$4.1M
$6.9M
Q3 25
$5.3M
$757.0K
Q2 25
$5.3M
$2.7M
Q1 25
$4.7M
$8.8M
Q4 24
$-321.0K
$9.9M
Q3 24
$4.3M
$2.1M
Q2 24
$1.3M
$7.6M
Q1 24
$2.3M
$8.6M
Gross Margin
NATR
NATR
VIASP
VIASP
Q4 25
72.5%
34.4%
Q3 25
73.3%
23.1%
Q2 25
71.7%
30.0%
Q1 25
72.1%
32.9%
Q4 24
72.0%
51.9%
Q3 24
71.3%
26.8%
Q2 24
71.4%
50.4%
Q1 24
71.2%
39.5%
Operating Margin
NATR
NATR
VIASP
VIASP
Q4 25
4.3%
15.2%
Q3 25
7.0%
3.1%
Q2 25
3.7%
6.7%
Q1 25
5.4%
17.5%
Q4 24
3.8%
31.5%
Q3 24
4.6%
5.3%
Q2 24
5.1%
23.8%
Q1 24
4.2%
22.6%
Net Margin
NATR
NATR
VIASP
VIASP
Q4 25
3.3%
5.4%
Q3 25
4.2%
0.7%
Q2 25
4.6%
3.0%
Q1 25
4.2%
6.2%
Q4 24
-0.3%
9.5%
Q3 24
3.8%
2.3%
Q2 24
1.2%
8.8%
Q1 24
2.1%
7.5%
EPS (diluted)
NATR
NATR
VIASP
VIASP
Q4 25
$0.23
$1.19
Q3 25
$0.30
$-0.41
Q2 25
$0.28
$0.09
Q1 25
$0.25
$1.83
Q4 24
$-0.02
$2.33
Q3 24
$0.23
$-0.17
Q2 24
$0.07
$1.51
Q1 24
$0.12
$1.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NATR
NATR
VIASP
VIASP
Cash + ST InvestmentsLiquidity on hand
$93.9M
$41.8M
Total DebtLower is stronger
$120.0M
Stockholders' EquityBook value
$161.6M
$67.7M
Total Assets
$261.1M
$331.3M
Debt / EquityLower = less leverage
1.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NATR
NATR
VIASP
VIASP
Q4 25
$93.9M
$41.8M
Q3 25
$95.6M
$53.6M
Q2 25
$81.3M
$62.1M
Q1 25
$86.5M
$64.7M
Q4 24
$84.7M
$53.1M
Q3 24
$78.7M
$66.6M
Q2 24
$68.7M
$53.6M
Q1 24
$77.8M
$50.4M
Total Debt
NATR
NATR
VIASP
VIASP
Q4 25
$120.0M
Q3 25
$105.0M
Q2 25
$100.0M
Q1 25
$101.0M
Q4 24
$106.0M
Q3 24
$89.0M
Q2 24
$93.0M
Q1 24
$2.1M
$91.0M
Stockholders' Equity
NATR
NATR
VIASP
VIASP
Q4 25
$161.6M
$67.7M
Q3 25
$166.7M
$63.7M
Q2 25
$163.7M
$68.2M
Q1 25
$167.1M
$72.7M
Q4 24
$161.0M
$66.7M
Q3 24
$162.6M
$58.2M
Q2 24
$156.4M
$58.3M
Q1 24
$159.7M
$53.2M
Total Assets
NATR
NATR
VIASP
VIASP
Q4 25
$261.1M
$331.3M
Q3 25
$264.8M
$304.8M
Q2 25
$254.9M
$316.3M
Q1 25
$252.7M
$347.4M
Q4 24
$240.9M
$344.9M
Q3 24
$245.3M
$298.4M
Q2 24
$235.8M
$299.7M
Q1 24
$247.3M
$302.7M
Debt / Equity
NATR
NATR
VIASP
VIASP
Q4 25
1.77×
Q3 25
1.65×
Q2 25
1.47×
Q1 25
1.39×
Q4 24
1.59×
Q3 24
1.53×
Q2 24
1.60×
Q1 24
0.01×
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NATR
NATR
VIASP
VIASP
Operating Cash FlowLast quarter
$9.9M
$-4.2M
Free Cash FlowOCF − Capex
$7.6M
$-4.8M
FCF MarginFCF / Revenue
6.1%
-3.7%
Capex IntensityCapex / Revenue
1.9%
0.4%
Cash ConversionOCF / Net Profit
2.41×
-0.61×
TTM Free Cash FlowTrailing 4 quarters
$28.8M
$39.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NATR
NATR
VIASP
VIASP
Q4 25
$9.9M
$-4.2M
Q3 25
$18.5M
$2.4M
Q2 25
$4.3M
$19.0M
Q1 25
$2.6M
$24.9M
Q4 24
$12.2M
$2.0M
Q3 24
$9.6M
$20.1M
Q2 24
$1.3M
$11.2M
Q1 24
$2.2M
$17.1M
Free Cash Flow
NATR
NATR
VIASP
VIASP
Q4 25
$7.6M
$-4.8M
Q3 25
$16.8M
$1.9M
Q2 25
$3.0M
$18.4M
Q1 25
$1.5M
$23.5M
Q4 24
$10.0M
$1.6M
Q3 24
$7.9M
$19.7M
Q2 24
$-2.0M
$10.9M
Q1 24
$-1.5M
$16.6M
FCF Margin
NATR
NATR
VIASP
VIASP
Q4 25
6.1%
-3.7%
Q3 25
13.1%
1.9%
Q2 25
2.6%
20.5%
Q1 25
1.3%
16.5%
Q4 24
8.5%
1.5%
Q3 24
6.9%
21.0%
Q2 24
-1.9%
12.6%
Q1 24
-1.4%
14.6%
Capex Intensity
NATR
NATR
VIASP
VIASP
Q4 25
1.9%
0.4%
Q3 25
1.3%
0.4%
Q2 25
1.2%
0.6%
Q1 25
1.0%
1.0%
Q4 24
1.9%
0.4%
Q3 24
1.5%
0.4%
Q2 24
3.0%
0.3%
Q1 24
3.3%
0.4%
Cash Conversion
NATR
NATR
VIASP
VIASP
Q4 25
2.41×
-0.61×
Q3 25
3.46×
3.12×
Q2 25
0.81×
6.94×
Q1 25
0.55×
2.84×
Q4 24
0.20×
Q3 24
2.21×
9.41×
Q2 24
0.97×
1.47×
Q1 24
0.94×
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

VIASP
VIASP

Retail Electricity$79.7M62%
Retail Natural Gas$48.9M38%

Related Comparisons